Company Overview

As of April 1, 2009, Cellegy Pharmaceuticals Inc. was acquired by Adamis Pharmaceuticals Corporation, in a reverse merger transaction. Cellegy Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company. The company, through its subsidiary, Biosyn, Inc., owns intellectual property relating to a portfolio of proprietary product candidates known as microbicides. It engages in the development and commercialization of prescription drugs, which include contraceptive and non-contraceptive microbicides used intravaginally and are intended to reduce transmission of sexually transmitted diseases, such as human immunodeficiency virus, acquired immunodeficiency disease, female sexual dysfun...

As of April 1, 2009, Cellegy Pharmaceuticals Inc. was acquired by Adamis Pharmaceuticals Corporation, in a reverse merger transaction. Cellegy Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company. The company, through its subsidiary, Biosyn, Inc., owns intellectual property relating to a portfolio of proprietary product candidates known as microbicides. It engages in the development and commercialization of prescription drugs, which include contraceptive and non-contraceptive microbicides used intravaginally and are intended to reduce transmission of sexually transmitted diseases, such as human immunodeficiency virus, acquired immunodeficiency disease, female sexual dysfunction, and gastrointestinal conditions primarily for women’s health care market. The company’s principal product candidates include Savvy, which underwent Phase 3 clinical trials in Ghana and Nigeria for anti-HIV microbicidal efficacy, and is currently in a Phase 3 contraception trial in the United States; and UC-781, a non-nucleoside reverse transcriptase inhibitor, which is in Phase 1 human safety studies, as well as in human anal/rectal efficacy studies. The company also develops Cyanovirin-N, a vaginal gel to prevent the sexual transmission. It operates in the United States, Europe, New Zealand, Singapore, and South Korea. Cellegy Pharmaceuticals was founded in 1989 and is headquartered in Boyertown, Pennsylvania.

Key Executives for Cellegy Pharmaceuticals Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions